{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:27:03Z","timestamp":1793593623459,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012551","name":"Sichuan Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.autrev.2026.104205","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:14:00Z","timestamp":1792624440000},"page":"104205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bidirectional regulation of the PD-1 pathway: Tumor immune exhaustion versus lupus nephritis T cells activation"],"prefix":"10.1016","volume":"26","author":[{"given":"Yachao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaijue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2026.104205_bb0005","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/cbf.3827","article-title":"Structure of PD1 and its mechanism in the treatment of autoimmune diseases","volume":"41","author":"Rezayi","year":"2023","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.autrev.2026.104205_bb0010","doi-asserted-by":"crossref","first-page":"eade6256","DOI":"10.1126\/sciimmunol.ade6256","article-title":"Transmembrane domain-driven PD-1 dimers mediate T cell inhibition","volume":"9","author":"Philips","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11427-024-2706-2","article-title":"Blocking the PD-1 signal transduction by occupying the phosphorylated ITSM recognition site of SHP-2","volume":"68","author":"Li","year":"2025","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.autrev.2026.104205_bb0020","doi-asserted-by":"crossref","first-page":"eaay4458","DOI":"10.1126\/sciadv.aay4458","article-title":"Molecular mechanism of SHP2 activation by PD-1 stimulation","volume":"6","author":"Marasco","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.autrev.2026.104205_bb0025","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3892\/ol.2024.14700","article-title":"PI3K\/AKT\/mTOR and PD-1\/CTLA-4\/CD28 pathways as key targets of cancer immunotherapy (review)","volume":"28","author":"Wang","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.autrev.2026.104205_bb0030","doi-asserted-by":"crossref","first-page":"E2480","DOI":"10.1073\/pnas.1305394110","article-title":"Strength of PD-1 signaling differentially affects T-cell effector functions","volume":"110","author":"Wei","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.autrev.2026.104205_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1119350","article-title":"Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2","volume":"14","author":"Taylor","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0040","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/s41591-021-01388-5","article-title":"Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child","volume":"27","author":"Ogishi","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.autrev.2026.104205_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008628","article-title":"Dysregulation of CD4(+) and CD8(+) resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis","volume":"12","author":"He","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.autrev.2026.104205_bb0050","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41467-024-45665-6","article-title":"Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis","volume":"15","author":"Mennillo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.autrev.2026.104205_bb0055","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.199694","article-title":"TNF-\u03b1 blockade mitigates immune checkpoint-related nephritis in a humanized mouse model","volume":"11","author":"Cuenca Narvaez","year":"2026","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2026.104205_bb0060","doi-asserted-by":"crossref","first-page":"eabg7836","DOI":"10.1126\/sciimmunol.abg7836","article-title":"A reservoir of stem-like CD8(+) T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response","volume":"6","author":"Connolly","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0065","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41590-021-00949-7","article-title":"Not-so-opposite ends of the spectrum: CD8(+) T cell dysfunction across chronic infection, cancer and autoimmunity","volume":"22","author":"Collier","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41584-025-01296-9","article-title":"PD-1, BTLA and TIGIT as therapeutic targets for rheumatic disease","volume":"22","author":"Kuchroo","year":"2026","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.autrev.2026.104205_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.10.025","article-title":"PD-1 immunobiology in systemic lupus erythematosus","volume":"97","author":"Curran","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.autrev.2026.104205_bb0080","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 during effector CD8 T cell differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.autrev.2026.104205_bb0085","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.autrev.2026.104205_bb0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0095","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","article-title":"Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.autrev.2026.104205_bb0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104205_bb0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.autrev.2026.104205_bb0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104205_bb0115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104205_bb0120","doi-asserted-by":"crossref","first-page":"eado3032","DOI":"10.1126\/sciimmunol.ado3032","article-title":"Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate","volume":"10","author":"Huang","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0125","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/s41590-024-01961-3","article-title":"Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control","volume":"25","author":"Weiss","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental relationships of four exhausted CD8(+) T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104205_bb0135","doi-asserted-by":"crossref","first-page":"eadg0539","DOI":"10.1126\/sciimmunol.adg0539","article-title":"PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors","volume":"8","author":"Gill","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0140","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","article-title":"Intratumoral dendritic cell-CD4(+) T helper cell niches enable CD8(+) T cell differentiation following PD-1 blockade in hepatocellular carcinoma","volume":"29","author":"Magen","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.autrev.2026.104205_bb0145","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1016\/j.ymthe.2025.09.006","article-title":"TOX-induced lnc-SUMF2-8 compromises antitumor function and anti-PD-1 response of CD8(+) T cells via lysosome-dependent degradation of TCF-1","volume":"33","author":"Jiang","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.autrev.2026.104205_bb0150","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104205_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091408","article-title":"Advancing cancer treatment: a review of immune checkpoint inhibitors and combination strategies","volume":"17","author":"Mc Neil","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.autrev.2026.104205_bb0160","article-title":"Overcoming resistance to PD-1 and CTLA-4 blockade mechanisms and therapeutic strategies","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0165","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241133","article-title":"BCOR and ZC3H12A suppress a core stemness program in exhausted CD8+ T cells","volume":"222","author":"Xu","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.autrev.2026.104205_bb0170","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.7150\/jca.108163","article-title":"Strategies to overcome PD-1\/PD-L1 blockade resistance: focusing on combination with immune checkpoint blockades","volume":"16","author":"Liu","year":"2025","journal-title":"J. Cancer"},{"key":"10.1016\/j.autrev.2026.104205_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70345","article-title":"Unravelling T cell exhaustion through co-inhibitory receptors and its transformative role in cancer immunotherapy","volume":"15","author":"Xiang","year":"2025","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.autrev.2026.104205_bb0180","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.7150\/thno.107418","article-title":"PD-1 activation mitigates lupus nephritis by suppressing hyperactive and heterogeneous PD-1(+)CD8(+) T cells","volume":"15","author":"Deng","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.autrev.2026.104205_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213928","article-title":"Exhausted but not senescent T lymphocytes predominate in lupus nephritis patients","volume":"23","author":"Lioulios","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.autrev.2026.104205_bb0190","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.4049\/jimmunol.1302725","article-title":"Differential kinetics of antigen dependency of CD4+ and CD8+ T cells","volume":"192","author":"Rabenstein","year":"2014","journal-title":"J. Immunol. (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.autrev.2026.104205_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189162","article-title":"T cell exhaustion in human cancers","volume":"1879","author":"Kang","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.autrev.2026.104205_bb0200","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.4049\/jimmunol.0800997","article-title":"Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion","volume":"182","author":"Bucks","year":"2009","journal-title":"J. Immunol. (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.autrev.2026.104205_bb0205","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104205_bb0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41577-025-01221-x","article-title":"Regulators of CD8(+) T cell exhaustion","volume":"26","author":"Sun","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11926-020-00978-5","article-title":"T cell abnormalities in the pathogenesis of systemic lupus erythematosus: an update","volume":"23","author":"Chen","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.autrev.2026.104205_bb0220","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/1529-0131(200010)43:10<2307::AID-ANR19>3.0.CO;2-J","article-title":"Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus","volume":"43","author":"Bruns","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2026.104205_bb0225","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.2004.02473.x","article-title":"Identification of systemically expanded activated T cell clones in MRL\/lpr and NZB\/W F1 lupus model mice","volume":"136","author":"Zhou","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.immuni.2013.11.017","article-title":"Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues","volume":"40","author":"Honda","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104205_bb0235","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1073\/pnas.1905675116","article-title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T cell exhaustion","volume":"116","author":"Seo","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.autrev.2026.104205_bb0240","article-title":"TMEM33 deletion potentiates anti-tumor CD8(+) T cell immunity","author":"Jackson","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.autrev.2026.104205_bb0245","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/2159-8290.CD-15-1347","article-title":"TGF\u03b21-mediated SMAD3 enhances PD-1 expression on antigen-specific T cells in Cancer","volume":"6","author":"Park","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.autrev.2026.104205_bb0250","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.156048","article-title":"Heterogeneity and clonality of kidney-infiltrating T cells in murine lupus nephritis","volume":"7","author":"Smita","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2026.104205_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1418527","article-title":"Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy","volume":"15","author":"Lopresti","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0260","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s40425-019-0719-5","article-title":"Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8(+) T cells","volume":"7","author":"Mastelic-Gavillet","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.autrev.2026.104205_bb0265","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/annonc\/mdw217","article-title":"Immune escape to PD-L1\/PD-1 blockade: seven steps to success (or failure)","volume":"27","author":"Kim","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.autrev.2026.104205_bb0270","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbagrm.2008.08.003","article-title":"Interferon-sensitive response element (ISRE) is mainly responsible for IFN-alpha-induced upregulation of programmed death-1 (PD-1) in macrophages","volume":"1779","author":"Cho","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.autrev.2026.104205_bb0275","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41590-022-01152-y","article-title":"Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells","volume":"23","author":"Sumida","year":"2022","journal-title":"Nat Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0280","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00262-018-2280-3","article-title":"Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8(+) T cells from negative regulation by local IFN-\u03b3","volume":"68","author":"Lin","year":"2019","journal-title":"Cancer Immunol. Immunother. : CII"},{"key":"10.1016\/j.autrev.2026.104205_bb0285","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/2326-6066.CIR-18-0243","article-title":"TLR stimulation during T-cell activation lowers PD-1 expression on CD8(+) T cells","volume":"6","author":"Zahm","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.autrev.2026.104205_bb0290","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1158\/0008-5472.CAN-16-2141","article-title":"Agonistic CD40 mAb-driven IL12 reverses resistance to anti-PD1 in a T-cell-rich tumor","volume":"76","author":"Ngiow","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.autrev.2026.104205_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155976","article-title":"Blockade of IL-6 inhibits tumor immune evasion and improves anti-PD-1 immunotherapy","volume":"158","author":"Li","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2026.104205_bb0300","doi-asserted-by":"crossref","first-page":"eadt4258","DOI":"10.1126\/sciadv.adt4258","article-title":"Deubiquitinase USP24 activated by IL-6\/STAT3 enhances PD-1 protein stability and suppresses T cell antitumor response","volume":"11","author":"Hsieh","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.autrev.2026.104205_bb0305","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1158\/0008-5472.CAN-18-0118","article-title":"Combined blockade of IL6 and PD-1\/PD-L1 Signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment","volume":"78","author":"Tsukamoto","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.autrev.2026.104205_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1600792","article-title":"Galectin-9 and Tim-3 in gastric cancer: a checkpoint axis driving T cell exhaustion and Treg-mediated immunosuppression independently of anti-PD-1 blockade","volume":"16","author":"Hill","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0315","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1038\/s41467-025-61822-x","article-title":"Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target","volume":"16","author":"Lla\u00f3-Cid","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.autrev.2026.104205_bb0320","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.immuni.2025.06.001","article-title":"The costimulatory molecule ICOS limits memory-like properties and function of exhausted PD-1(+)CD8(+) T cells","volume":"58","author":"Humblin","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104205_bb0325","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.immuni.2015.02.015","article-title":"Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus","volume":"42","author":"Teichmann","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104205_bb0330","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/09612033241247908","article-title":"Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-Yaa mice","volume":"33","author":"Moriyama","year":"2024","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2026.104205_bb0335","first-page":"962","article-title":"Expression and significance of PD-1 on CD4(+); and CD8(+); T cells from the peripheral blood of patients with systemic lupus erythematosus","volume":"29","author":"Wang","year":"2013","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10.1016\/j.autrev.2026.104205_bb0340","article-title":"T peripheral helper cells in autoimmune diseases: what do we know?","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0345","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.chembiol.2022.05.012","article-title":"Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating notch signaling","volume":"29","author":"Geng","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.autrev.2026.104205_bb0350","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.autrev.2026.104205_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2024.107461","article-title":"Interplay between CD28 and PD-1 in T cell immunotherapy","volume":"158","author":"Jafri","year":"2025","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.autrev.2026.104205_bb0360","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.4049\/jimmunol.1700608","article-title":"The Ox40\/Ox40 ligand pathway promotes pathogenic Th cell responses, plasmablast accumulation, and lupus nephritis in NZB\/W F1 mice","volume":"199","author":"Sitrin","year":"2017","journal-title":"J. Immunol. (Baltimore, Md : 1950)"},{"key":"10.1016\/j.autrev.2026.104205_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102499","article-title":"CD137 \/ CD137 ligand signalling regulates the immune balance: a potential target for novel immunotherapy of autoimmune diseases","volume":"112","author":"Wong","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.autrev.2026.104205_bb0370","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1172\/JCI120859","article-title":"Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted","volume":"128","author":"Tilstra","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.autrev.2026.104205_bb0375","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130062","article-title":"PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21","volume":"4","author":"Bocharnikov","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2026.104205_bb0385","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000480641","article-title":"The systemic activation of programmed death 1-PD-L1 axis protects systemic lupus erythematosus model from nephritis","volume":"46","author":"Liao","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.autrev.2026.104205_bb0390","doi-asserted-by":"crossref","first-page":"835","DOI":"10.4049\/jimmunol.1801617","article-title":"Conditional upregulation of IFN-\u03b1 alone is sufficient to induce systemic lupus erythematosus","volume":"203","author":"Akiyama","year":"2019","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.autrev.2026.104205_bb0395","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4049\/jimmunol.1300652","article-title":"Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor control","volume":"191","author":"Gerner","year":"2013","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.autrev.2026.104205_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103440","article-title":"Efficacy and safety of Janus kinase inhibitors in systemic and cutaneous lupus erythematosus: a systematic review and meta-analysis","volume":"22","author":"Ma","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2026.104205_bb0405","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-005932","article-title":"Metabolomic profiling of patients with lupus nephritis reveals unique metabolites that are modulated through type I interferon inhibition by anifrolumab treatment in a phase 2 trial","volume":"11","author":"Gavin","year":"2025","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2026.104205_bb0410","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41591-025-04157-w","article-title":"Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial","volume":"32","author":"Yap","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.autrev.2026.104205_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102774","article-title":"Tackling of immunorefractory tumors by targeting alternative immune checkpoints","volume":"15","author":"Dulal","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.autrev.2026.104205_bb0430","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/acr2.11745","article-title":"Therapeutic JAK1 inhibition reverses lupus nephritis in a mouse model and demonstrates transcriptional changes consistent with human disease","volume":"6","author":"Twomey","year":"2024","journal-title":"ACR Open Rheumatol."},{"key":"10.1016\/j.autrev.2026.104205_bb0425","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/ndt\/gfae184","article-title":"Immune checkpoint inhibitor-associated nephritis-treatment standard","volume":"39","author":"Barbir","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.autrev.2026.104205_bb0420","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.kint.2024.09.017","article-title":"Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrology","volume":"107","author":"Herrmann","year":"2025","journal-title":"Kidney Int."},{"key":"10.1016\/j.autrev.2026.104205_bb0440","article-title":"The effect of combining PD-1 agonist and low-dose interleukin-2 on treating systemic lupus erythematosus","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0445","article-title":"Editorial: the role of negative immune checkpoints in the treatment of systemic lupus erythematosus and rheumatoid arthritis","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2026.104205_bb0450","article-title":"Immune checkpoint inhibitors and lupus erythematosus","volume":"17","author":"Vitzthum von Eckstaedt","year":"2024","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.autrev.2026.104205_bb0435","doi-asserted-by":"crossref","unstructured":"I.T.C. Ling, S.J. Marciniak, S.H. Clarke, V. Lakshminarayanan, M.J. Loza, S.G. Liva, T. Wang, A. Orillion, I. Tikhonov and E.H. Noss. Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multiple-dose phase Ib study. Ther Adv Musculoskelet Dis 2025;17:1759720x251385857.","DOI":"10.1177\/1759720X251385857"},{"key":"10.1016\/j.autrev.2026.104205_bb0455","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/1759-7714.13405","article-title":"Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor-induced renal immune-related adverse events","volume":"11","author":"Zheng","year":"2020","journal-title":"Thoracic cancer"},{"key":"10.1016\/j.autrev.2026.104205_bb0380","article-title":"Terminally exhausted CD8(+) T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology","volume":"16","author":"Guo","year":"2025","journal-title":"Front. Immunol."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226002193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226002193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T03:55:25Z","timestamp":1793591725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226002193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S1568997226002193"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104205","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bidirectional regulation of the PD-1 pathway: Tumor immune exhaustion versus lupus nephritis T cells activation","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104205"}}